$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
肝脏功能差的患者可以服用多吉美吗?
2025-10-19 11:44:20
Check Details
肝癌患者怎么买到多吉美?
2025-10-19 11:44:20
Check Details
肝癌神药多吉美了解一下!
2025-10-19 11:44:20
Check Details
两种治疗肝癌的多吉美该如何选择?
2025-10-19 11:44:20
Check Details
卡博替尼适应症中的靶点以及推荐服用剂量
2025-10-19 11:44:20
Check Details
多种癌症服用卡博替尼具有很好的控制率
2025-10-19 11:44:20
Check Details
乐伐替尼晚期HCC患者的新选择
2025-10-19 11:44:20
Check Details
肝炎的程度对索拉菲尼的总生存期影响很大
2025-10-19 11:44:20
Check Details
复发性肝癌唯一的靶向药物--索拉菲尼
2025-10-19 11:44:20
Check Details
HCV肝癌患者服用索拉菲尼治疗可获得更多受益
2025-10-19 11:44:20
Check Details
乐伐替尼治疗肝癌有效率
2025-10-19 11:44:20
Check Details
仑伐替尼治疗肝癌有哪些优势?
2025-10-19 11:44:20
Check Details
1
2
...
2557
2558
2559
2560
2561
2562
2563
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
4
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
5
Complete Guide to Dosage and Dose Adjustment of Entrectinib
6
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
7
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
8
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
9
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
10
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
11
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
12
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety